MG
CLMT icon

Michael Gelband’s Calumet Specialty Products CLMT Stock Holding History

Michael Gelband’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Sell
10,162
-87,259
-90% -$2.93M ﹤0.01% 1312
2026
Q1 		$3.5M Buy
+97,421
New +$2.52M 0.03% 558
2025
Q4 		– Sell
-31,023
Closed -$566K – 1608
2025
Q3 		$566K Buy
+31,023
New +$510K 0.01% 1141
2025
Q2 		– Sell
-59,941
Closed -$760K – 1526
2025
Q1 		$760K Buy
+59,941
New +$941K 0.01% 993

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Michael Gelband's CLMT Position: Q2 2026 in Review

Michael Gelband reduced its Calumet Specialty Products (CLMT) stake by 90% in Q2 2026, selling an estimated $2.93M and leaving 10,162 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #1312.

Michael Gelband first reported a position in CLMT in Q1 2025 and has held it in 4 quarters since. The position peaked at $3.5M in Q1 2026. 187 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Michael Gelband held 10,162 shares of Calumet Specialty Products worth $366K as of Q2 2026.
  • Michael Gelband sold 87,259 Calumet Specialty Products shares in Q2 2026, an estimated $2.93M.
  • Calumet Specialty Products made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1312 holding.
  • Michael Gelband first reported a position in Calumet Specialty Products in Q1 2025 and has held it in 4 quarters since.
  • Michael Gelband's Calumet Specialty Products position peaked at $3.5M in Q1 2026.
  • 187 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.